Back to search

Article

Molecular profiling and personalized medicine within EURACAN in the SPECTA Arcagen study in comparison to the France Genomic Medicine 2025 Plan in the AURAGEN platform in peritoneal mesotheliomas

2025-03-31

Abstract excerpt

<title>Abstract</title> <p>Peritoneal mesothelioma (PM) is a rare aggressive cancer with limited treatment options upon progression. Genomic profiling European (Arcagen cohort) and French (AURAGEN cohort) initiatives aim to guide treatments for rare cancers. This study presents the initial findings from these efforts. Molecular analysis (n = 56, 55.4% females, mean 55.9 years) showed a high success rate to identi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
95528d54-e776-5a4e-a3b5-682616cea0b8
DOI
10.21203/rs.3.rs-5699044/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular profiling and personalized medicine within EURACAN in the SPECTA Arcagen study in comparison to the France Genomic Medicine 2025 Plan in the AURAGEN platform in peritoneal mesotheliomasDOI 10.21203/rs.3.rs-5699044/v1
Genomic characterization and detection of potential therapeutic targets for peritoneal mesothelioma in current practice.Semantic proximity
Comprehensive genomic and transcriptomic analysis enables molecularly guided therapy options in peritoneal and pleural mesotheliomaSemantic proximity
Molecular alterations and potential actionable mutations in peritoneal mesothelioma: a scoping review of high-throughput sequencing studies.Semantic proximity
Precision Oncology in Metastatic Uterine Cancer; Croatian First-Year Experience of the Comprehensive Genomic Profiling in Everyday Clinical Practice.Semantic proximity
Personalized Oncogenomics: Clinical Experience with Malignant Peritoneal Mesothelioma Using Whole Genome SequencingSemantic proximity
Assessing the Impact of Comprehensive Genomic Profiling on Therapeutic Selection for Advanced Solid Tumors in PortugalSemantic proximity
Inactivation of BAP1 and the Hippo Pathway Defines the Mutational Landscape of Peritoneal MesotheliomaSemantic proximity
BAP1 Loss Predicts Therapeutic Vulnerability in Malignant Peritoneal MesotheliomaSemantic proximity
Comprehensive Genomic Profiling in Metastatic Solid Tumors: High Actionability But Low Implementation in Real-World PracticeSemantic proximity
Epigenetic genes alterations in metastatic solid tumors: results from the prospective precision medicine MOSCATO and MATCH-R trialsSemantic proximity
Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumorsSemantic proximity
Genomic Landscape of Malignant Mesotheliomas.Semantic proximity
Select a neighboring publication to make it the new centre.